findmyKOL

Elena Barengolts

Basic profile

University of Illinois Chicago

ORCIDNone on fileNPI
RegionArlington Heights, IL · MidwestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH funding2011–2014Why? →

Elena Barengolts is an Endocrinology/Metabolic physician affiliated with University of Illinois Chicago. OpenAlex indexes 47 publications with 1,125 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
47publications

Distinct works indexed by OpenAlex.

1,125citations

Total citations across indexed works.

17h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
45companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2011–2014

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3365 N Arlington Heights Rd Ste K
Arlington Heights, IL 600047700

Telephone

847-870-1702

Provider last certified this registry record 14 Dec 2020.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

45 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    82.8%
    Biguanide (metformin)17.8%
    Metformin Hcl66%Metformin Hcl Er34%
    Part D125 patients
    Sulfonylurea16.6%
    Glimepiride85%Glipizide12%Glipizide Er3%
    Part D<11 patients

    + 7 more classes in this area

  • Cardiovascular

    8.7%
    Statin2%
    Rosuvastatin Calcium56%Atorvastatin Calcium44%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)1.9%
    Losartan Potassium60%Losartan-Hydrochlorothiazide40%
    Part D<11 patients

    + 7 more classes in this area

  • Hormonal (systemic)

    6.5%
    l-Thyroxine5.1%
    Levothyroxine Sodium100%
    Part D46 patients
    Thyroid Hormone Synthesis Inhibitor1.4%
    Methimazole100%
    Part D14 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20112014 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”